Next Article in Journal
Methylation Profiling in Diffuse Gliomas: Diagnostic Value and Considerations
Next Article in Special Issue
Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET
Previous Article in Journal
Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease
Previous Article in Special Issue
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review
 
 
Article

Article Versions Notes

Cancers 2022, 14(22), 5680; https://doi.org/10.3390/cancers14225680
Action Date Notes Link
article xml file uploaded 18 November 2022 16:04 CET Original file -
article xml uploaded. 18 November 2022 16:04 CET Update -
article pdf uploaded. 18 November 2022 16:04 CET Version of Record https://www.mdpi.com/2072-6694/14/22/5680/pdf-vor
article supplementary file uploaded. 18 November 2022 16:04 CET - https://www.mdpi.com/2072-6694/14/22/5680#supplementary
article html file updated 18 November 2022 16:05 CET Original file -
article xml file uploaded 21 November 2022 05:39 CET Update -
article xml uploaded. 21 November 2022 05:39 CET Update https://www.mdpi.com/2072-6694/14/22/5680/xml
article pdf uploaded. 21 November 2022 05:39 CET Updated version of record https://www.mdpi.com/2072-6694/14/22/5680/pdf
article html file updated 21 November 2022 05:40 CET Update -
article html file updated 28 February 2023 23:47 CET Update -
article html file updated 3 March 2023 21:13 CET Update https://www.mdpi.com/2072-6694/14/22/5680/html
Back to TopTop